REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nipro Medical Corporation (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Nipro Medical Corporation Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Nipro Medical Corporation is an enterprise in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on May 03, 2002. The total number of employees is currently 107 (2021). In 2023, the company reported a net sales revenue drop of 20.77%. During that time, Nipro Medical Corporation’s total assets decreased by 1.97%. In, 2023, the company’s net profit margin decreased by 3.7%.

Headquarters
el Arenal Oe11-192
Quito; Pichincha;

Contact Details: Purchase the Nipro Medical Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Nipro Medical Corporation report to view the information.
Outstanding Shares:
Purchase the Nipro Medical Corporation report to view the information.
Registered Capital:
Purchase the Nipro Medical Corporation report to view the information.
Incorporation Date:
May 03, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Nipro Medical Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-20.77%▼
Total operating revenue
-20.82%▼
Operating profit (EBIT)
-95.75%▼
EBITDA
78.26%▲
Net Profit (Loss) for the Period
-738.42%▼
Total assets
-1.97%▼
Total equity
-8.61%▼
Operating Profit Margin (ROS)
-0.94%▼
Net Profit Margin
-3.7%▼
Return on Equity (ROE)
-8.39%▼
Quick Ratio
0.02%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo